JCP AMMUNITION ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.7% 11.8% 9.6% 11.2% 4.9%  
Credit score (0-100)  24 20 24 21 43  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  58.9 22.6 102 70.3 167  
EBITDA  58.9 22.6 102 70.3 167  
EBIT  58.9 22.6 102 70.3 165  
Pre-tax profit (PTP)  54.5 15.1 92.4 57.4 138.9  
Net earnings  42.4 11.7 72.1 44.6 108.2  
Pre-tax profit without non-rec. items  54.5 15.1 92.4 57.4 139  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 43.2  
Shareholders equity total  122 91.7 152 125 188  
Interest-bearing liabilities  124 206 215 326 440  
Balance sheet total (assets)  257 308 396 490 657  

Net Debt  88.1 112 112 210 423  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  58.9 22.6 102 70.3 167  
Gross profit growth  72.5% -61.6% 350.6% -31.1% 137.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  257 308 396 490 657  
Balance sheet change%  31.1% 19.8% 28.5% 23.6% 34.1%  
Added value  58.9 22.6 102.0 70.3 167.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 41  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 98.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  26.0% 8.0% 29.0% 15.9% 28.9%  
ROI %  27.6% 8.3% 30.7% 17.2% 30.7%  
ROE %  37.1% 10.9% 59.1% 32.2% 69.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  47.6% 29.8% 38.4% 25.4% 28.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  149.6% 496.5% 109.5% 298.6% 253.0%  
Gearing %  101.1% 224.6% 141.6% 262.0% 233.6%  
Net interest  0 0 0 0 0  
Financing costs %  4.4% 4.5% 4.5% 4.8% 6.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.3 0.4 0.4 0.3 0.0  
Current Ratio  1.9 1.4 1.6 1.3 1.3  
Cash and cash equivalent  35.6 93.7 103.7 116.5 16.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  122.4 91.7 152.1 124.6 145.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0